📌 Key Takeaways
- Topic: Silica Specification Sheet: Key Parameters to Check Before Buying
- Keywords: what is silica
- Published: 2026-11-20 04:17:49
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Antiblocking Agent: How It Works, Particle Size Selection and Uses
- Silica Sol Manufacturer: Product Types, Quality Control and How to Choose
- Silica as a Moisture Absorber: How It Works and How Much You Need
- 79. Wang Y., Cheng W., Zhu J., He L., Ren W., Bao D., Piao J.-G. Programmed Co-delivery of tamoxifen and docetaxel utilizing lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment. Biomed. Pharmacother. 2024;170:116084. doi: 10.1016/j.biopha.2023.116084. [ DOI ] [ PubMed ] [ Google Scholar ]
- Silica for Paint: Matting, Anti-Settling and Rheology Functions Explained
- MDPI and/or the editor(s) disclaim responsibility for any injury to individuals or property resulting from any ideas, methods, instructions or products referred to in the content.
- Silica Price per Ton: 2026 Price Ranges by Type and Grade
Silica Particle Size Guide: How D50, Mesh and Microns Affect Performance
What is silica (SiO₂)?
silica gel
What is the difference between fumed silica and precipitated silica?
crystalline silica powder
What drives silica raw material prices?
silica supplier Brazil Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.